Palisade Bio Stock Buy Hold or Sell Recommendation
| PALI Stock | USD 2.42 0.02 0.83% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Palisade Bio is 'Cautious Hold'. The recommendation algorithm takes into account all of Palisade Bio's available fundamental, technical, and predictive indicators you will find on this site.
Check out Palisade Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide. In addition, we conduct extensive research on individual companies such as Palisade and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Palisade Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Palisade |
Execute Palisade Bio Buy or Sell Advice
The Palisade recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Palisade Bio. Macroaxis does not own or have any residual interests in Palisade Bio or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Palisade Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Palisade Bio Trading Alerts and Improvement Suggestions
| Palisade Bio generated a negative expected return over the last 90 days | |
| Palisade Bio has high historical volatility and very poor performance | |
| Palisade Bio has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 250 K. Net Loss for the year was (12.3 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Palisade Bio currently holds about 5 M in cash with (11.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23. | |
| Palisade Bio has a poor financial position based on the latest SEC disclosures | |
| Latest headline from thelincolnianonline.com: Palisade Bio Now Covered by Brookline Capital Management |
Palisade Bio Returns Distribution Density
The distribution of Palisade Bio's historical returns is an attempt to chart the uncertainty of Palisade Bio's future price movements. The chart of the probability distribution of Palisade Bio daily returns describes the distribution of returns around its average expected value. We use Palisade Bio price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Palisade Bio returns is essential to provide solid investment advice for Palisade Bio.
| Mean Return | -0.42 | Value At Risk | -8.55 | Potential Upside | 5.97 | Standard Deviation | 4.86 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Palisade Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Palisade Stock Institutional Investors
| Shares | Armistice Capital, Llc | 2024-09-30 | 52 K | Ubs Group Ag | 2024-06-30 | 1.2 K | Tower Research Capital Llc | 2024-06-30 | 738 | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 280 | Federation Des Caisses Desjardins Du Quebec | 2024-06-30 | 100.0 | Wells Fargo & Co | 2024-06-30 | 21.0 | Bank Of America Corp | 2024-06-30 | 5.0 | Fidelity Management And Research Company | 2024-06-30 | 0.0 |
Palisade Bio Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (672.2K) | (2.9M) | 9.8M | 1.9M | 49K | 46.6K | |
| Free Cash Flow | (7.3M) | (4.8M) | (14.8M) | (13.4M) | (11.1M) | (11.7M) | |
| Depreciation | 185.8K | 143.9K | 3K | 2K | 4K | 3.8K | |
| Other Non Cash Items | 774.3K | 1.2M | 34.8M | (1.4M) | 139K | 132.1K | |
| Net Income | (8.4M) | (10.3M) | (26.6M) | (14.3M) | (12.3M) | (12.9M) | |
| End Period Cash Flow | 5.1M | 739K | 10.5M | 12.4M | 12.5M | 8.5M | |
| Change To Inventory | 37.0K | 15.7K | (947K) | (84K) | (96.6K) | (101.4K) |
Palisade Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Palisade Bio or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Palisade Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Palisade stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.33 | |
β | Beta against Dow Jones | -0.79 | |
σ | Overall volatility | 4.90 | |
Ir | Information ratio | -0.11 |
Palisade Bio Volatility Alert
Palisade Bio exhibits very low volatility with skewness of 0.5 and kurtosis of 3.32. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Palisade Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Palisade Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Palisade Bio Fundamentals Vs Peers
Comparing Palisade Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Palisade Bio's direct or indirect competition across all of the common fundamentals between Palisade Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Palisade Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Palisade Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Palisade Bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Palisade Bio to competition |
| Fundamentals | Palisade Bio | Peer Average |
| Return On Equity | -1.1 | -0.31 |
| Return On Asset | -0.59 | -0.14 |
| Current Valuation | (3.98 M) | 16.62 B |
| Shares Outstanding | 1.33 M | 571.82 M |
| Shares Owned By Insiders | 1.88 % | 10.09 % |
| Shares Owned By Institutions | 3.57 % | 39.21 % |
| Number Of Shares Shorted | 114.68 K | 4.71 M |
| Price To Earning | 0.16 X | 28.72 X |
| Price To Book | 0.56 X | 9.51 X |
| Price To Sales | 14.03 X | 11.42 X |
| Revenue | 250 K | 9.43 B |
| EBITDA | (12.28 M) | 3.9 B |
| Net Income | (12.3 M) | 570.98 M |
| Cash And Equivalents | 5 M | 2.7 B |
| Cash Per Share | 0.23 X | 5.01 X |
| Total Debt | 369 K | 5.32 B |
| Debt To Equity | 0.23 % | 48.70 % |
| Current Ratio | 2.59 X | 2.16 X |
| Book Value Per Share | 18.30 X | 1.93 K |
| Cash Flow From Operations | (11.13 M) | 971.22 M |
| Short Ratio | 0.29 X | 4.00 X |
| Earnings Per Share | (13.26) X | 3.12 X |
| Target Price | 30.33 | |
| Number Of Employees | 9 | 18.84 K |
| Beta | 1.33 | -0.15 |
| Market Capitalization | 3.7 M | 19.03 B |
| Total Asset | 14.05 M | 29.47 B |
| Retained Earnings | (121.51 M) | 9.33 B |
| Working Capital | 10.74 M | 1.48 B |
| Net Asset | 14.05 M |
Note: Disposition of 4558 shares by Jones Mitchell Lawrence of Palisade Bio subject to Rule 16b-3 [view details]
Palisade Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Palisade . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0403 | |||
| Daily Balance Of Power | 0.2 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 2.43 | |||
| Day Typical Price | 2.43 | |||
| Market Facilitation Index | 0.1 | |||
| Period Momentum Indicator | 0.02 |
About Palisade Bio Buy or Sell Advice
When is the right time to buy or sell Palisade Bio? Buying financial instruments such as Palisade Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Palisade Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Toys Thematic Idea Now
Toys
Companies producing and distributing toys and different gaming products for kids. The Toys theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Toys Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Palisade Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palisade Bio. If investors know Palisade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.26) | Return On Assets (0.59) | Return On Equity (1.10) |
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Palisade Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Palisade Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palisade Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.